Literature DB >> 12695441

Who would I not give IIb/IIIa inhibitors to during percutaneous coronary intervention?

J M McLenachan.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12695441      PMCID: PMC1767642          DOI: 10.1136/heart.89.5.477

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  6 in total

1.  Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial.

Authors:  J C O'Shea; G E Hafley; S Greenberg; V Hasselblad; T J Lorenz; M M Kitt; J Strony; J E Tcheng
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  A simple benchmark for evaluating quality of care of patients following acute myocardial infarction.

Authors:  M F Dorsch; R A Lawrance; R J Sapsford; J Oldham; D C Greenwood; B M Jackson; C Morrell; S G Ball; M B Robinson; A S Hall
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

3.  Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.

Authors:  Eric Boersma; Robert A Harrington; David J Moliterno; Harvey White; Pierre Théroux; Frans Van de Werf; Anneke de Torbal; Paul W Armstrong; Lars C Wallentin; Robert G Wilcox; John Simes; Robert M Califf; Eric J Topol; Maarten L Simoons
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

4.  Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.

Authors:  E J Topol
Journal:  Lancet       Date:  2001-06-16       Impact factor: 79.321

5.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.

Authors:  D R Thiemann; J Coresh; S P Schulman; G Gerstenblith; W J Oetgen; N R Powe
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

6.  Deaths associated with platelet glycoprotein IIb/IIIa inhibitor treatment.

Authors:  D L Brown
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.